CD4 and acute respiratory distress syndrome: Earlier case reports on HIV-positive patients receiving systemic anthracycline-based therapy described adverse outcomes, including neutropenic sepsis, acute respiratory distress syndrome, Candida esophagitis, and death.14,23 Our patients started ART at initiation of chemotherapy regardless of CD4 count, per national ART guidelines.